Publications
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine, First Faculty of Medicine
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine, First Faculty of Medicine
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
- Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Erratum - Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Im-munity in a Group of Women with Multiple Sclerosis (vol 86, pg 334, 2023)2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- The problematics of post-stroke disability assessment2023 | Faculty of Medicine in Pilsen
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis2022 | Faculty of Medicine in Pilsen
Loading network view...